ArticleVeterinary research2025
Temporally integrated multiomics analysis elucidates intricate regulatory mechanisms of ASFV in a wild boar lung-derived clonal cell line.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
African swine fever virus (ASFV) is a large double-stranded DNA virus that poses a significant threat to the global pig industry. Currently, our understanding of ASFV biology remains limited, as there is a lack of suitable cell lines to support its propagation and analysis. Here, we optimized a wild boar lung cell line to increase its susceptibility to ASFV, followed by temporally integrated transcriptomic and proteomic analyses of ASFV infection. Multiomics analysis revealed more than 17,000 genes and 5100 proteins, with 1594 differentially expressed genes (DEGs) and 923 differentially expressed proteins (DEPs) identified. Temporal dynamics revealed stage-specific host modulation: early-phase DEPs orchestrated metabolic reprogramming and transmembrane transport via the solute carrier superfamily (e.g., SLC25A, SLC30A, and SLC44A2), whereas the late infection phase featured concurrent upregulation of innate immune effectors (e.g., Mx1, OAS1, ISG15, and TRIM21) and suppression of apoptosis inhibitors (e.g., TMEM192, PDCD4, and DPP9), suggesting synchronized antiviral activation and apoptotic regulation. Unexpectedly, siRNA-mediated knockdown of key DEGs or DEPs involved in antiviral immunity, interferon signalling, DNA repair, genome stability, immune regulation, the inflammatory response and vesicular transport did not significantly affect viral replication. Only knockdown of the genes STX17 and ZNF512 significantly impaired ASFV replication. This systematic investigation provides a comprehensive framework for further studies of ASFV-host interactions, identifies candidate host dependency/support factors and establishes critical groundwork for the development of targeted antiviral interventions and next-generation vaccine platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.